000 | 01820 a2200541 4500 | ||
---|---|---|---|
005 | 20250516133415.0 | ||
264 | 0 | _c20131001 | |
008 | 201310s 0 0 eng d | ||
022 | _a1522-9653 | ||
024 | 7 |
_a10.1016/j.joca.2013.01.016 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLosina, E | |
245 | 0 | 0 |
_aDisease-modifying drugs for knee osteoarthritis: can they be cost-effective? _h[electronic resource] |
260 |
_bOsteoarthritis and cartilage _cMay 2013 |
||
300 |
_a655-67 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAge Factors |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAnti-Inflammatory Agents _xadverse effects |
650 | 0 | 4 |
_aArthroplasty, Replacement, Knee _xeconomics |
650 | 0 | 4 | _aCost-Benefit Analysis |
650 | 0 | 4 | _aDisease Progression |
650 | 0 | 4 |
_aDrug Costs _xstatistics & numerical data |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHealth Care Costs _xstatistics & numerical data |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aModels, Econometric |
650 | 0 | 4 |
_aOsteoarthritis, Knee _xcomplications |
650 | 0 | 4 |
_aPain _xetiology |
650 | 0 | 4 | _aQuality of Life |
650 | 0 | 4 | _aSensitivity and Specificity |
650 | 0 | 4 | _aUnited States |
700 | 1 | _aDaigle, M E | |
700 | 1 | _aSuter, L G | |
700 | 1 | _aHunter, D J | |
700 | 1 | _aSolomon, D H | |
700 | 1 | _aWalensky, R P | |
700 | 1 | _aJordan, J M | |
700 | 1 | _aBurbine, S A | |
700 | 1 | _aPaltiel, A D | |
700 | 1 | _aKatz, J N | |
773 | 0 |
_tOsteoarthritis and cartilage _gvol. 21 _gno. 5 _gp. 655-67 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.joca.2013.01.016 _zAvailable from publisher's website |
999 |
_c22476427 _d22476427 |